- Home
- EVM vs CRBU Comparison
EVM vs CRBU Comparison
Compare EVM & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVM
- CRBU
- Stock Information
- Founded
- EVM 2002
- CRBU 2011
- Country
- EVM United States
- CRBU United States
- Employees
- EVM N/A
- CRBU N/A
- Industry
- EVM Finance/Investors Services
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- EVM Finance
- CRBU Health Care
- Exchange
- EVM Nasdaq
- CRBU Nasdaq
- Market Cap
- EVM 213.2M
- CRBU 188.8M
- IPO Year
- EVM N/A
- CRBU 2021
- Fundamental
- Price
- EVM $9.03
- CRBU $1.87
- Analyst Decision
- EVM
- CRBU Strong Buy
- Analyst Count
- EVM 0
- CRBU 4
- Target Price
- EVM N/A
- CRBU $8.50
- AVG Volume (30 Days)
- EVM 55.8K
- CRBU 1.9M
- Earning Date
- EVM 01-01-0001
- CRBU 08-12-2025
- Dividend Yield
- EVM 4.01%
- CRBU N/A
- EPS Growth
- EVM N/A
- CRBU N/A
- EPS
- EVM 0.20
- CRBU N/A
- Revenue
- EVM N/A
- CRBU $9,918,000.00
- Revenue This Year
- EVM N/A
- CRBU $9.52
- Revenue Next Year
- EVM N/A
- CRBU N/A
- P/E Ratio
- EVM $47.61
- CRBU N/A
- Revenue Growth
- EVM N/A
- CRBU N/A
- 52 Week Low
- EVM $7.67
- CRBU $0.66
- 52 Week High
- EVM $9.59
- CRBU $3.00
- Technical
- Relative Strength Index (RSI)
- EVM 68.73
- CRBU 53.41
- Support Level
- EVM $8.65
- CRBU $1.86
- Resistance Level
- EVM $9.07
- CRBU $2.13
- Average True Range (ATR)
- EVM 0.08
- CRBU 0.22
- MACD
- EVM 0.05
- CRBU -0.05
- Stochastic Oscillator
- EVM 100.00
- CRBU 15.76
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.